GlassScriptPhysician profile
Scott P Guidry
NPI 1316959018
$20,589.10
in general payments reported to CMS, 2019-2025
24 companies · $1,517 in 2025
The $1,517 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $146 · 2021: $240 · 2022: $1,989 · 2023: $377 · 2024: $454 · 2025: $1,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575 · Travel and Lodging: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,574.85 |
| Travel and Lodging | $772.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,405.61 | 2019-2025 | |
| Enterra Medical, INC. | $956.26 | 2025 | |
| Ethicon US, LLC | $523.21 | 2019-2025 | Vistaseal, N/A, Megadyne |
| Abbvie INC. | $294.81 | 2023-2025 | |
| Davol INC. | $249.50 | 2019-2024 | Phasix Mesh |
| Allergan, INC. | $202.43 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $156.30 | 2019-2023 | Bridion |
| Hologic Sales and Service, LLC | $138.25 | 2023-2024 | Localizer, Biozorb, Coolseal Generator |
| Baxter Healthcare | $112.25 | 2019-2025 | Tisseel |
| Kerecis Limited | $110.98 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Takeda Pharmaceuticals U.S.A., INC. | $92.91 | 2023-2025 | Gattex |
| Mallinckrodt Enterprises LLC | $60.24 | 2019 | |
| Mallinckrodt Hospital Products INC. | $40.86 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $38.97 | 2023-2025 | Myrisk |
| Smith+Nephew, INC. | $32.41 | 2019-2024 | Tc-100, Allevyn Life L 15.4x15.4 Ctn10, Acticoat 4" X 4" |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $29.88 | 2020-2022 | |
| Shire North American Group INC | $29.11 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $29.11 | 2021 | |
| Tei Biosciences INC | $19.89 | 2019 | |
| Lemaitre Vascular, INC. | $14.84 | 2022 | |
| Innocoll Pharmaceuticals Limited | $14.73 | 2022 | |
| Tela Bio, INC. | $12.71 | 2019 | |
| Covidien LP | $12.01 | 2019 | |
| Abbott Laboratories | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Guidry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.